Top Story

Breast conservation surgery plus radiotherapy confers better survival outcomes than mastectomy

March 27, 2015

Women with stage I to stage III breast cancer who underwent breast-conserving surgery plus radiotherapy demonstrated significantly improved all-cause and breast cancer-specific survival compared with those who underwent mastectomy, according to a retrospective analysis of outcomes of patients treated in a public health care setting in Canada.

Previous randomized trials suggested patients with early-stage breast cancer who undergo mastectomy demonstrated outcomes comparable to those who underwent mastectomy plus breast conserving surgery. However, recent studies conducted in the United States and Canada have started to reveal a survival benefit for breast conserving surgery plus radiotherapy, according to study background.

In the Journals

Late mortality, morbidity rates increase among survivors of adult Hodgkin's lymphoma

March 27, 2015
Survivors of adult Hodgkin’s lymphoma face high risks for late mortality from other causes, as well as late medical morbidity, according to study results.Medical…
Breaking News

Senate adjourns without voting on bill to repeal sustainable growth rate

March 27, 2015
The U.S. Senate left for its 2-week spring break without voting on a bill that repeals the sustainable growth rate, leaving physicians to face a 21% payment cut if…
FDA News

FDA grants orphan drug designation to CRS-207 for mesothelioma

March 27, 2015
The FDA granted orphan drug designation to CRS-207 — a novel immuno-oncology product candidate — for the treatment of patients with malignant pleural…
Guy Young, MD In the Journals

Investigation programs needed for study of risks in use of pediatric anticoagulant drugs

March 27, 2015
The International Society on Thrombosis and Haemostasis called for the development of pediatric investigative programs to study risks of anticoagulants in children and…
More News Headlines »
CME
Hot melanoma

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates - Monograph

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »
Meeting News Coverage Video
thumbnail for video 4124118507001

3D printing has applications, challenges in a variety of medical specialties

March 20, 2015
SAN FRANCISCO — Scott Hollister, PhD, professor of biomedical engineering at the University of Michigan, talks…
More »
CME
Activity cover

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates

This activity is supported by an educational grant from Merck & Co., Inc.

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »
morganatic-roan
morganatic-roan